Wall Street estimates the weight-loss drug market to be worth $150 billion by 2030, with Lilly and Novo together controlling the majority of projected global sales
Eli Lilly becomes first drugmaker to hit trillion-dollar m-cap on weight-loss demand boom
📅 Published: November 21, 2025 |
📂 Category: Uncategorized